| Action Summary | House Bill 1738 enacted by the 2015 General Assembly requires any hospice licensed by the Virginia Department of Health or exempt from licensure pursuant to ยง 32.1-162.2 of the Code of Virginia with a hospice patient residing at home at the time of death to notify every pharmacy that has dispensed partial quantities of a Schedule II controlled substance for a patient with a medical diagnosis documenting a terminal illness, as authorized by federal law, within 48 hours of the patient's death. The Virginia Department of Health is utilizing this exempt action to amend the Regulations for the Licensure of Hospice (12VAC5-391 et. seq.) to reflect this new requirement. |
| Chapters Affected | Only affects this chapter. |
| Executive Branch Review | This Action is exempt from Article 2 of the Administrative Process Act. The normal executive branch review process is not required. As such, it can be submitted directly for publication and is effective upon publication. Exempt Citation: Section 2.2-4006 A4a |
| RIS Project | Yes [004524] |
| Associated Mandates |
Chapter: 668 (2015)
|
| New Periodic Review | This action will not be used to conduct a new periodic review. |
| Stage ID | Stage Type | Status |
|---|---|---|
| 7418 | Final | Stage complete. This regulation became effective on 04/07/2016. |
| Name / Title: | Rebekah E. Allen / Sr. Policy Analyst |
| Address: |
Virginia Department of Health 9960 Mayland Drive, Ste. 401 Richmond, VA 23233 |
| Email Address: | regulatorycomment@vdh.virginia.gov |
| Phone: | (804)367-2102 FAX: (804)527-4502 TDD: ()- |